Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Damien Slater, Ph.D.

Concepts (60)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Damien Slater's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Damien Slater has written about over time.
PC12 Cells, 1 publications between 2003 and 2003, average publication date April 2003. Dystonia Musculorum Deformans, 1 publications between 2004 and 2004, average publication date December 2003. Carrier State, 1 publications between 2020 and 2020, average publication date October 2020. Immunoglobulin M, 2 publications between 2020 and 2020, average publication date October 2020. Coronavirus Infections, 1 publications between 2020 and 2020, average publication date October 2020. Genome, Viral, 1 publications between 2020 and 2020, average publication date December 2020. Phylogeny, 1 publications between 2020 and 2020, average publication date December 2020. Antibodies, Viral, 3 publications between 2020 and 2021, average publication date December 2020. Immunoglobulin G, 3 publications between 2020 and 2021, average publication date December 2020. Laboratories, Hospital, 1 publications between 2021 and 2021, average publication date May 2021. Disease Outbreaks, 2 publications between 2020 and 2022, average publication date December 2021. Cholera, 1 publications between 2022 and 2022, average publication date November 2022. Communicable Diseases, Emerging, 1 publications between 2022 and 2022, average publication date November 2022.

To see the data from this visualization as text, click here.
Slater's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (60)
Explore
_
Co-Authors (33)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.